Polyvascular disease and risk: When two is not better than one.

Bonaca, Marc P

Bonaca, Marc P.

Affiliation

Bonaca MP; TIMI Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, MA, USA.

Vasc Med ; 23(6): 531-533, 2018 12.

Article in En | MEDLINE | ID: mdl-30232940

Subject(s)

Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Fibrinolytic Agents; Peripheral Arterial Disease; Thrombosis; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/prevention & control; Cerebrovascular Disorders/complications; Cerebrovascular Disorders/drug therapy; Coronary Artery Disease/complications; Coronary Artery Disease/drug therapy; Fibrinolytic Agents/classification; Fibrinolytic Agents/pharmacology; Humans; Patient Selection; Peripheral Arterial Disease/complications; Peripheral Arterial Disease/drug therapy; Risk Assessment; Risk Factors; Secondary Prevention/methods; Severity of Illness Index; Thrombosis/etiology; Thrombosis/prevention & control

Key words

antiplatelet therapy; antithrombotic therapy; cardiovascular disease; coronary artery disease; peripheral artery disease (PAD)

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Coronary Artery Disease / Cardiovascular Diseases / Cerebrovascular Disorders / Peripheral Arterial Disease / Fibrinolytic Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Vasc Med Journal subject: ANGIOLOGIA Year: 2018 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google